Search Results - "Ljungman, P T"

Comparison of upfront tandem autologous–allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma by Sahebi, F, Iacobelli, S, Biezen, A V, Volin, L, Dreger, P, Michallet, M, Ljungman, P T, de Witte, T, Henseler, A, Schaap, N P M, López-Corral, L, Poire, X, Passweg, J, Hamljadi, R-M, Thomas, S H, Schonland, S, Gahrton, G, Morris, C, KrÖger, N, Garderet, L

“…We performed a retrospective analysis of the European Group for Blood and Marrow Transplantation database comparing the outcomes of multiple myeloma patients…”
Get full text

Antifungal Therapy Strategies in Hematopoietic Stem-Cell Transplant Recipients : Early Treatment Options for Improving Outcomes by CHANDRASEKAR, Pranatharthi, LJUNGMAN, Per T

“…Changes in clinical practice permit more patients to undergo hematopoietic stem-cell transplantation but also have increased the risk for invasive fungal…”
Get full text

Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation by Marty, Francisco M., Ljungman, Per T., Chemaly, Roy F., Wan, Hong, Teal, Valerie L., Butterton, Joan R., Yeh, Wendy W., Leavitt, Randi Y., Badshah, Cyrus S.

“…Letermovir, a cytomegalovirus (CMV) terminase‐complex inhibitor, is indicated for prophylaxis of CMV infection and disease in adult CMV‐seropositive recipients…”
Get full text

Handling of Allogeneic HPC Grafts in European Transplant Centers during the COVID-19 Pandemic - a Survey from the Infectious Diseases and Cellular Therapy & Immunobiology Working Parties of the EBMT by Worel, Nina, Ljungman, Per T, Sánchez-Ortega, Isabel, Hoogenboom, Jorinde D, Knelange, Nina S, Verheggen, Inge CM, Eikema, Dirk-Jan, Ruggeri, Annalisa, Kuball, Jurgen, Averbuch, Diana, De La Camara, Rafael, Chabannon, Christian

Get full text

Naive Donor NK Cell Repertoires Associated with Less Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation by Björklund, Andreas T, Clancy, Trevor, Goodridge, Jodie P, Béziat, Vivien, Schaffer, Marie, Hovig, Eivind, Ljunggren, Hans-Gustaf, Ljungman, Per T, Malmberg, Karl-Johan

“…Acute and latent human CMV cause profound changes in the NK cell repertoire, with expansion and differentiation of educated NK cells expressing self-specific…”
Get full text

ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT by Canaani, Jonathan, Savani, Bipin N., Labopin, Myriam, Michallet, Mauricette, Craddock, Charles, Socié, Gerard, Volin, Lisa, Maertens, Johan A., Crawley, Charles, Blaise, Didier, Ljungman, Per T., Cornelissen, Jan, Russell, Nigel, Baron, Frédéric, Gorin, Norbert, Esteve, Jordi, Ciceri, Fabio, Schmid, Christoph, Giebel, Sebastian, Mohty, Mohamad, Nagler, Arnon

“…ABO incompatibility is commonly observed in stem cell transplantation and its impact in this setting has been extensively investigated. HLA‐mismatched…”
Get full text

Epidemiology and Outcomes of Respiratory Virus Infections in Adult Acute Leukemia and Hematopoietic Stem Cell Transplant Patients by Trikha, Gaurav, Conway, Rebecca, Hiemenz, John W, Ljungman, Per T.

“…BACKGROUND Respiratory virus infections (RVI) are significant cause of morbidity and mortality in adult patients with hematopoietic stem cell transplant (HSCT)…”
Get full text

Treatment of Chronic GvHD with Mesenchymal Stromal Cells Induces Durable Responses; A Phase II Study by Von Bahr, Lena, Davies, Lindsay, Afram, Gabriel, Modin, Carina, Garming-Legert, Karin, Hägglund, Hans, Ljungman, Per T., Le Blanc, Katarina

“…Introduction Chronic graft-versus-host disease (cGvHD) is major cause of late morbidity and mortality after allogeneic hematopoietic stem cell transplantation,…”
Get full text

Early and Transient Microchimerism Associated with Complete Remission after Adoptively Transferred Haploidentical NK Cells Against High Risk Myelodysplastic Syndrome and Refractory Acute Myeloid Leukemia by Björklund, Andreas T, Carlsten, Mattias, Schaffer, Marie, Liu, Lisa, Cooley, Sarah A., Miller, Jeffrey S., Watz, Emma, Palma, Marzia, Hansson, Lotta, Wahlin, Björn E, Möllgård, Lars, Hagglund, Hans, Blomberg, Pontus, Ljungman, Per T., Hellström-Lindberg, Eva, Ljunggren, Hans-Gustaf, Malmberg, Karl-Johan

“…Introduction: We here report from an ongoing phase I/II study of HLA-haploidentical NK cell therapy to patients with high-risk myelodysplastic syndrome (MDS)…”
Get full text

Donor CMV Status Influence On the Outcome of Allogeneic Stem Cell Transplantation (HSCT); A Study by the Infectious Diseases Working Party (IDWP) of the EBMT by Ljungman, Per T., Brand, Ronald, De La Camara, Rafael, Cordonnier, Catherine, Einsele, Hermann, Styczynski, Jan, Ward, Katherine N., Cesaro, Simone

“…Abstract ▪465▪This icon denotes a clinically relevant abstract A previous study from the IDWP of the EBMT showed that CMV seropositive patients undergoing…”
Get full text

Reduced Intensity Allogeneic Stem Cell Transplant In Patients With Multiple Myeloma: A Comparison Of Planned Autologous-Reduced Intensity Allogeneic Stem Cell Transplant (Auto-Allo) and Reduced Intensity Allogeneic Stem Cell Transplant (RIC) As Upfront Transplant In Patients With Multiple Myeloma, An EBMT Analysis by Sahebi, Firoozeh, Iacobelli, Simona, Van Biezen, Anja, Volin, Liisa, Dreger, Peter, Michallet, Mauricette, Ljungman, Per T., Gahrton, Goesta, Morris, Curly TCM, Schonland, Stefan, de Witte, Theo, Garderet, Laurent, Kroeger, Nicolaus, Henseler, Anja, Schaap, Nicolaas PM, Caballero, D, Poire, Xavier, Passweg, Jakob, Hamljadi, Rose-Marie

“…Despite the advances in the treatment of multiple myeloma using new targeted therapies and autologous hematopoietic stem cell transplant (HSCT) the disease…”
Get full text

Risk Factors for Overall Survival in Patients with Acute Myeloid Leukemia (AML) with Normal Karyotype Undergoing Allogeneic Stem Cell Transplantation (allo-SCT) in First Complete Remission (CR1): A Report On 366 Patients From the Acute Leukemia Working Party of EBMT by Schmid, Christoph, Labopin, Myriam, Deconinck, Eric, Attal, Michel, Socié, Gérard, Vigouroux, Stephane, Volin, Liisa, Ifrah, Norbert, Rambaldi, Alessandro, Rossi, Jean-Francois, Blaise, Didier, Cornelissen, Jan, Ljungman, Per T., Brune, Mats L, Bordigoni, Pierre, Vernant, Jean-Paul, Yakoub-Agha, Ibrahim, Pogliani, Enrico Maria, Michallet, Mauricette, Arcese, William, Polge, Emmanuelle, Esteve, Jordi, Mohty, Mohamad

“…Abstract 1975▪▪This icon denotes a clinically relevant abstract Among patients with AML with normal cytogenetics (CN-AML), the presence or absence of the NPM1…”
Get full text

ADOPTIVELY TRANSFERRED HAPLOIDENTICAL NK CELLS AGAINST REFRACTORY MDS, HIGH-RISK MDS AND REFRACTORY AML AS A BRIDGE TO TRANSPLANTATION. COMPLETE REMISSION ASSOCIATED WITH DETECTABLE NK CELLS by Bjorklund, AT, Carlsten, M, Liu, L, Schaffer, M, Watz, E, Palma, M, Hansson, L, Mollgard, L, Cooley, SA, Miller, JS, Ljungman, PT, Hellstrom-Lindberg, E, Ljunggren, HG, Malmberg, KJ

Get full text

Prospecitve Quantitative PCR Monitoring of Allogeneic Stem Cell Transplant (SCT) Patients at High Risk for EBV Associated PTLD by Omar, Hamdy, Hägglund, Hans, Gustafsson-Jernberg, Åsa, Le Blanc, Katarina, Mattsson, Jonas, Remberger, Mats, Ringdén, Olle, Sparrelid, Elda, Sundin, Mikael, Winiarski, Jacek H., Yun, Zhibing, Ljungman, Per T.

“…Background: EBV associated PTLD is a severe complication after allogeneic SCT with high mortality. Several studies have reported identified risk factors for…”
Get full text

Norovirus Infections in Patients with Hematological Diseases and After Stem Cell Transplantation; Epidemiological and Clinical Aspects by Ljungman, PT, Bernell, P, Lerner, R, Mattsson, J, Ostlund, MR, Sparrelid, E, Orvell, C

Get full text

Fatal infectious complications developing late after allogeneic stem cell transplantation by Bjorklund, A, Aschan, J, Ringden, O, Winiarski, JH, Ljungman, PT

Get full text

Factors influencing measles immunity after allogeneic stem cell transplantation by Ljungman, PT, Niemela, K, Aschan, J, Barkholt, L, Gustafsson, B, Winiarski, JH, Ringden, O

Get full text

Donor CMV serostatus influences outcome after unrelated donor stem cell transplantation; An EBMT megafile analysis by Ljungman, PT, Brand, R, Einsele, H, Niederwieser, D, Cordonnier, C

Get full text

INTERIM REPORT OF A CLINICAL STUDY WITH HAPLOIDENTICAL NK-CELLS AGAINST HIGH RISK MDS AND AML by Bjorklund, AT, Carlsten, M, Liu, L, Schaffer, M, Watz, E, Cooley, S, Miller, JS, Hellstrom-Lindberg, E, Ljungman, PT, Ljunggren, HG, Malmberg, KJ

Get full text

Prospective comparison of PCR-based versus late mRNA-based preemptive antiviral therapy for HCMV infection in patients after allogeneic stem cell transplantation by Hebart, HF, Ljungman, PT, Klingebiel, T, Loeffler, J, Lewensohn-Fuchs, I, Barkhold, L, Top, B, Razonable, RR, Patel, R, Litzow, M, Kanz, L, Jahn, G, Einsele, H

Get full text